Skip to main content
. 2022 Feb 11;15(2):288–298. doi: 10.14202/vetworld.2022.288-298

Figure-5.

Figure-5

Oral administration of piperine inhibits lipid peroxidation due to monosodium urate-induced gout inflammation, thereby suppressing malondialdehyde (MDA) levels. (a) Serum MDA levels in protocol I. (b) Serum MDA levels in protocol II. Values on the graph are represented as mean±SD (n=3 rats/group).